CNST insider filings

CONSTELLATION PHARMACEUTICALS INC — 33 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-07-23. Screen CNST transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for CNST between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — CONSTELLATION PHARMACEUTICALS INC

FiledFormInsiderReported transactionsSource
2021-07-234/AHoerter Steven L. — DirectorDisposition to issuer (D): 26,342 (derivative)EDGAR
2021-07-194Humphrey Jeffrey — Chief Medical OfficerDisposition to issuer (D): 133,000 (derivative) · Disposition to issuer (D): 35,055 (derivative)EDGAR
2021-07-194Valentine Karen — See RemarksDisposition to issuer (D): 58,600 (derivative) · Disposition to issuer (D): 81,939 (derivative) · Disposition to issuer (D): 22,425 (derivative) · Disposition to issuer (D): 41,800 (derivative)EDGAR
2021-07-194Trehu Elizabeth — DirectorDisposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 26,342 (derivative) · Disposition to issuer (D): 13,171 (derivative)EDGAR
2021-07-194Trojer Patrick — Chief Scientific OfficerDisposition to issuer (D): 72,050 (derivative) · Disposition to issuer (D): 22,708 (derivative) · Disposition to issuer (D): 78,000 (derivative) · Disposition to issuer (D): 43,387 (derivative) · Disposition to issuer (D): 850 (derivative) · Disposition to issuer (D): 33,330 (derivative) · +4 moreEDGAR
2021-07-194Reeve Emma — Chief Financial OfficerDisposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 37,527 (derivative) · Disposition to issuer (D): 73,428 (derivative) · Disposition to issuer (D): 11,777 (derivative) · Disposition to issuer (D): 17,666 (derivative) · Disposition to issuer (D): 80,971 (derivative) · +1 moreEDGAR
2021-07-194Raythatha Jigar — See Remarks, DirectorDisposition to issuer (D): 14,961 · Disposition to issuer (D): 200,000 (derivative) · Disposition to issuer (D): 306,938 (derivative) · Disposition to issuer (D): 245,000 (derivative) · Disposition to issuer (D): 141,929 (derivative) · Disposition to issuer (D): 141,929 (derivative) · +2 moreEDGAR
2021-07-194Hoerter Steven L. — DirectorDisposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 26,342 (derivative) · Disposition to issuer (D): 13,171 (derivative)EDGAR
2021-07-194Braunstein Scott — DirectorDisposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 26,342 (derivative) · Disposition to issuer (D): 13,171 (derivative)EDGAR
2021-07-194Audia James E — DirectorDisposition to issuer (D): 25,434 · Disposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 8,175 (derivative) · Disposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 1,277 (derivative) · Disposition to issuer (D): 9,083 (derivative) · +5 moreEDGAR
2021-07-194Levy Richard S — DirectorDisposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 26,342 (derivative)EDGAR
2021-07-194GOLDSMITH MARK A — DirectorDisposition to issuer (D): 89,857 · Disposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 6,825 (derivative) · Disposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 12,446 (derivative) · Disposition to issuer (D): 9,083 (derivative) · +1 moreEDGAR
2021-06-044Braunstein Scott — DirectorGrant/award (A): 13,171 (derivative) @ $0EDGAR
2021-06-044Trehu Elizabeth — DirectorGrant/award (A): 13,171 (derivative) @ $0EDGAR
2021-06-044Hoerter Steven L. — DirectorGrant/award (A): 13,171 (derivative) @ $0EDGAR
2021-06-044Audia James E — DirectorGrant/award (A): 13,171 (derivative) @ $0EDGAR
2021-06-044Levy Richard S — DirectorGrant/award (A): 13,171 (derivative) @ $0EDGAR
2021-06-044GOLDSMITH MARK A — DirectorGrant/award (A): 13,171 (derivative) @ $0EDGAR
2021-03-084GOLDSMITH MARK A — DirectorOption exercise (M): 14,987 @ $0 · Option exercise (M): 14,987 (derivative) @ $0EDGAR
2021-02-234Reeve Emma — Chief Financial OfficerOption exercise (M): 4,010 @ $8.04 · Sale (S): 4,010 @ $37.71 · Option exercise (M): 6,260 @ $8.04 · Sale (S): 6,260 @ $37.60 · Option exercise (M): 4,010 (derivative) @ $0 · Option exercise (M): 6,260 (derivative) @ $0EDGAR
2021-02-194Reeve Emma — Chief Financial OfficerOption exercise (M): 410 @ $8.04 · Sale (S): 410 @ $37.56 · Option exercise (M): 1,100 @ $8.04 · Sale (S): 1,100 @ $37.58 · Option exercise (M): 410 (derivative) @ $0 · Option exercise (M): 1,100 (derivative) @ $0EDGAR
2021-02-194COLUMN GROUP L P — 10% owner
COLUMN GROUP III, LP — 10% owner
COLUMN GROUP III-A, LP — 10% owner
COLUMN GROUP III GP, LP — 10% owner
COLUMN GROUP GP, LP — 10% owner
PONOI CAPITAL, LP — 10% owner
Ponoi Management, LLC — 10% owner
Ponoi Capital II, LP — 10% owner
Ponoi II Management, LLC — 10% owner
Kutzkey Tim — 10% owner
Sale (S): 10,000 @ $36.95EDGAR
2021-02-194COLUMN GROUP L P — 10% owner
GOEDDEL DAVID V — 10% owner
Svennilson Peter — 10% owner
Sale (S): 10,000 @ $36.95EDGAR
2021-02-184Humphrey Jeffrey — Chief Medical OfficerGrant/award (A): 35,055 (derivative) @ $0EDGAR
2021-02-184Raythatha Jigar — See Remarks, DirectorGrant/award (A): 204,500 (derivative) @ $0EDGAR
2021-02-184Valentine Karen — See RemarksGrant/award (A): 58,600 (derivative) @ $0EDGAR
2021-02-184Trojer Patrick — Chief Scientific OfficerGrant/award (A): 72,050 (derivative) @ $0EDGAR
2021-02-184Reeve Emma — Chief Financial OfficerGrant/award (A): 66,950 (derivative) @ $0EDGAR
2021-01-204Valentine Karen — See RemarksOption exercise (M): 17,203 @ $11.50 · Sale (S): 8,773 @ $33.08 · Sale (S): 1,227 @ $33.69 · Sale (S): 7,203 @ $35.11 · Option exercise (M): 17,203 (derivative) @ $0EDGAR
2020-12-284GOLDSMITH MARK A — Director, 10% ownerSale (S): 4,020 @ $35.02EDGAR
2020-12-224Reeve Emma — Chief Financial OfficerOption exercise (M): 1,178 @ $7.60 · Option exercise (M): 4,542 @ $6.61 · Sale (S): 5,720 @ $35.11 · Option exercise (M): 1,178 (derivative) @ $0 · Option exercise (M): 4,542 (derivative) @ $0EDGAR
2020-12-164COLUMN GROUP L P — 10% owner
COLUMN GROUP III, LP — 10% owner
COLUMN GROUP III-A, LP — 10% owner
COLUMN GROUP III GP, LP — 10% owner
COLUMN GROUP GP, LP — 10% owner
PONOI CAPITAL, LP — 10% owner
Ponoi Management, LLC — 10% owner
Ponoi Capital II, LP — 10% owner
Ponoi II Management, LLC — 10% owner
Kutzkey Tim — 10% owner
Option exercise/expiry (X): 30,107 @ $1.55 · Option exercise/expiry (X): 30,107 (derivative) @ $0EDGAR
2020-12-164COLUMN GROUP L P — 10% owner
GOEDDEL DAVID V — 10% owner
Svennilson Peter — 10% owner
Option exercise/expiry (X): 30,107 @ $1.55 · Option exercise/expiry (X): 30,107 (derivative) @ $0EDGAR

Recent 8-K events — CONSTELLATION PHARMACEUTICALS INC

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2021-07-158-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2021-06-028-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2021-06-028-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2020-12-078-K8.01 — Other EventsEDGAR
2020-11-188-K1.01 — Entry into a Material Definitive AgreementEDGAR
2020-11-098-K1.02 — Termination of a Material Definitive AgreementEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CNST returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs